| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP6V0C TMC1 HCN4 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 SLC17A6 | 2.00e-14 | 758 | 125 | 28 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP6V0C TMC1 HCN4 SLC38A9 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SLC2A6 SCN3A SCN4A SCN5A SCN8A LRP5 ABCC12 ABCC2 ATP2A3 SLC14A2 SLC17A6 | 2.75e-14 | 1180 | 125 | 34 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ATP6V0C TMC1 HCN4 SLC38A9 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 IGF1R SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SLC2A6 SCN3A SCN4A SCN5A SCN8A LRP5 ABCC12 ABCC2 ATP2A3 SLC14A2 SLC17A6 | 6.03e-14 | 1289 | 125 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP6V0C TMC1 HCN4 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A ATP2A3 SLC17A6 | 4.38e-13 | 793 | 125 | 27 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TMC1 HCN4 HCN3 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC1A7 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ATP2A3 SLC17A6 | 1.10e-11 | 465 | 125 | 20 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP6V0C TMC1 HCN4 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC1A7 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ATP2A3 SLC17A6 | 4.87e-11 | 627 | 125 | 22 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP6V0C TMC1 HCN4 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC1A7 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ATP2A3 SLC17A6 | 1.46e-10 | 664 | 125 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | HCN4 HCN3 SLC34A2 SLC13A3 SLC34A3 SLC1A7 SLC13A4 SCN3A SCN4A SCN5A SCN8A SLC17A6 | 8.04e-10 | 171 | 125 | 12 | GO:0015081 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP6V0C SLC26A2 TCIRG1 SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC39A12 SLC13A4 SLC30A5 SLC11A1 ABCC12 ABCC2 ATP2A3 SLC17A6 | 1.06e-09 | 477 | 125 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1M1 IL13RA1 OR8D1 OR5M9 RAMP3 HTR2B HTR2C SPN TAS1R3 OR13C8 GRM1 GRM3 OR5AR1 PLXNB2 SLAMF1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 IGF1R LRP5 CCR3 TNFRSF1B NMBR TM2D1 OR52A1 NOTCH1 NOTCH2 | 3.52e-09 | 1353 | 125 | 29 | GO:0004888 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP6V0C TCIRG1 SLC34A2 SLC13A3 SLC34A3 SLC4A3 SLC1A7 SLC4A1 SLC39A12 SLC13A4 SLC30A5 SLC11A1 ATP2A3 SLC17A6 | 6.33e-09 | 301 | 125 | 14 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | SLC26A2 SLC34A2 SLC34A3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 CLCN2 CLCNKA ABCC2 SLC17A6 | 1.05e-08 | 171 | 125 | 11 | GO:0015103 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.11e-08 | 26 | 125 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A2 SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC39A12 SLC13A4 SLC30A5 SLC11A1 SLC17A6 | 4.46e-08 | 296 | 125 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1M1 OR8D1 OR5M9 RAMP3 HTR2B HTR2C TAS1R3 OR13C8 GRM1 GRM3 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR TM2D1 OR52A1 | 5.93e-07 | 884 | 125 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium channel activity | 8.58e-07 | 52 | 125 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A9 SLC26A2 SLC13A3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC39A12 SLC2A6 ABCC2 SLC17A6 | 2.37e-06 | 293 | 125 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | symporter activity | SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC1A7 SLC39A12 SLC13A4 SLC17A6 | 4.71e-06 | 150 | 125 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ATP6V0C TMC1 HCN4 HCN3 SLC1A7 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 6.25e-06 | 459 | 125 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.97e-06 | 119 | 125 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.18e-05 | 81 | 125 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.38e-05 | 125 | 125 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | channel activity | ATP6V0C TMC1 HCN4 HCN3 SLC1A7 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 2.59e-05 | 525 | 125 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ATP6V0C TMC1 HCN4 HCN3 SLC1A7 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 2.64e-05 | 526 | 125 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.59e-05 | 32 | 125 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.66e-05 | 151 | 125 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 5.06e-05 | 12 | 125 | 3 | GO:0005436 | |
| GeneOntologyMolecularFunction | sodium ion binding | 8.29e-05 | 14 | 125 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | Gq/11-coupled serotonin receptor activity | 1.16e-04 | 3 | 125 | 2 | GO:0001587 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.64e-04 | 44 | 125 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.34e-04 | 138 | 125 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 2.53e-04 | 20 | 125 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.13e-04 | 343 | 125 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.30e-04 | 207 | 125 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.40e-04 | 208 | 125 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 3.86e-04 | 431 | 125 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 4.40e-04 | 24 | 125 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 4.40e-04 | 24 | 125 | 3 | GO:0005385 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.60e-04 | 26 | 125 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 5.80e-04 | 61 | 125 | 4 | GO:1901682 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.16e-04 | 109 | 125 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 6.28e-04 | 27 | 125 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 9.47e-04 | 31 | 125 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.01e-03 | 182 | 125 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.03e-03 | 71 | 125 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.04e-03 | 32 | 125 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 1.04e-03 | 32 | 125 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.07e-03 | 184 | 125 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | odorant binding | 1.23e-03 | 127 | 125 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.36e-03 | 9 | 125 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.36e-03 | 9 | 125 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.36e-03 | 9 | 125 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | TAP complex binding | 1.36e-03 | 9 | 125 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.69e-03 | 10 | 125 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.69e-03 | 10 | 125 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.69e-03 | 10 | 125 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.69e-03 | 10 | 125 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.69e-03 | 10 | 125 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.06e-03 | 11 | 125 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 2.06e-03 | 11 | 125 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | chloride channel activity | 2.09e-03 | 86 | 125 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.30e-03 | 42 | 125 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.46e-03 | 43 | 125 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.46e-03 | 12 | 125 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | serotonin binding | 2.90e-03 | 13 | 125 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 2.90e-03 | 13 | 125 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 2.90e-03 | 13 | 125 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 2.90e-03 | 13 | 125 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.90e-03 | 13 | 125 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.90e-03 | 13 | 125 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 3.87e-03 | 15 | 125 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.02e-03 | 103 | 125 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.30e-03 | 105 | 125 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 4.40e-03 | 16 | 125 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 4.97e-03 | 17 | 125 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.97e-03 | 17 | 125 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.10e-03 | 334 | 125 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 5.28e-03 | 178 | 125 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | MHC protein binding | 5.75e-03 | 58 | 125 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 6.20e-03 | 19 | 125 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 6.63e-03 | 188 | 125 | 5 | GO:0015078 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 6.86e-03 | 20 | 125 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 6.92e-03 | 62 | 125 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | amine binding | 7.55e-03 | 21 | 125 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 8.27e-03 | 22 | 125 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | ankyrin binding | 9.03e-03 | 23 | 125 | 2 | GO:0030506 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP6V0C TMC1 HTR2B HTR2C HCN4 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 ITGB3 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 2.54e-15 | 1017 | 121 | 32 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP6V0C TMC1 HTR2B HTR2C HCN4 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 ITGB3 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 3.27e-14 | 1115 | 121 | 32 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP6V0C TMC1 RAMP3 HTR2B HTR2C HCN4 SLC26A2 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC10A7 ITGB3 SLC4A3 SLC1A7 SLC4A1 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 3.04e-13 | 1374 | 121 | 34 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP6V0C TMC1 HTR2B HTR2C HCN4 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 ITGB3 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 1.93e-11 | 922 | 121 | 26 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP6V0C TMC1 HTR2B HTR2C HCN4 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 ITGB3 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 3.10e-11 | 942 | 121 | 26 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6V0C TMC1 RAMP3 HTR2B HTR2C HCN4 HCN3 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC10A7 ITGB3 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 1.01e-10 | 1157 | 121 | 28 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | TMC1 RAMP3 HTR2B HTR2C HCN4 HCN3 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC10A7 ITGB3 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 KCNC1 SCN3A SCN4A SCN5A SCN8A ABCC2 ATP2A3 JPH3 SLC17A6 | 1.14e-10 | 1000 | 121 | 26 | GO:0030001 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 SLC34A2 SLC34A3 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 IGF1R SLC30A5 SLC11A1 LRP5 ABCC2 ATP2A3 JPH3 | 5.87e-09 | 866 | 121 | 22 | GO:0055082 |
| GeneOntologyBiologicalProcess | inorganic anion transport | SLC26A2 SLC34A2 SLC34A3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 SLC11A1 CLCN2 CLCNKA SLC17A6 | 9.15e-09 | 180 | 121 | 11 | GO:0015698 |
| GeneOntologyBiologicalProcess | cellular homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 SLC34A2 SLC34A3 TXNRD2 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 IGF1R SLC30A5 SLC11A1 LRP5 ABCC2 ATP2A3 JPH3 | 1.13e-08 | 981 | 121 | 23 | GO:0019725 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 SLC30A5 SLC11A1 ABCC2 ATP2A3 JPH3 | 2.36e-08 | 622 | 121 | 18 | GO:0006873 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | HCN4 HCN3 SLC34A2 SLC13A3 SLC34A3 SLC13A4 SCN3A SCN4A SCN5A SCN8A SLC17A6 | 4.08e-08 | 208 | 121 | 11 | GO:0035725 |
| GeneOntologyBiologicalProcess | sodium ion transport | HCN4 HCN3 SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC13A4 SCN3A SCN4A SCN5A SCN8A SLC17A6 | 8.00e-08 | 275 | 121 | 12 | GO:0006814 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 SLC30A5 SLC11A1 ATP2A3 JPH3 | 1.06e-07 | 611 | 121 | 17 | GO:0030003 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | HTR2B HTR2C TCIRG1 SLC34A2 SLC34A3 TUNAR GRM1 SLC10A7 ITGB3 SLC30A7 FRRS1 SLC30A5 SLC11A1 ABCC2 ATP2A3 JPH3 SLC17A6 | 1.36e-07 | 622 | 121 | 17 | GO:0098771 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 SLC30A5 SLC11A1 ABCC2 ATP2A3 JPH3 | 1.99e-07 | 717 | 121 | 18 | GO:0050801 |
| GeneOntologyBiologicalProcess | chemical homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 SLC34A2 SLC34A3 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 ITGB6 SLC4A1 SLC30A7 SLC39A12 FRRS1 IGF1R SLC30A5 SLC11A1 LRP5 ABCC2 ATP2A3 JPH3 SLC17A6 | 2.21e-07 | 1249 | 121 | 24 | GO:0048878 |
| GeneOntologyBiologicalProcess | organic anion transport | HTR2C SLC38A9 SLC26A2 ARL6IP5 SLC13A3 GRM1 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC39A12 SLC11A1 SLC2A6 ABCC2 SLC17A6 | 3.55e-07 | 515 | 121 | 15 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | ATP6V0C HTR2B HTR2C TCIRG1 TUNAR GRM1 SLC10A7 ITGB3 SLC4A3 SLC4A1 SLC30A7 SLC39A12 FRRS1 SLC30A5 SLC11A1 ATP2A3 JPH3 | 7.85e-07 | 705 | 121 | 17 | GO:0055080 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.25e-06 | 134 | 121 | 8 | GO:0098661 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.08e-06 | 36 | 121 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | amino acid transport | HTR2C SLC38A9 ARL6IP5 SLC13A3 GRM1 SLC1A7 SLC11A1 LRP5 SLC17A6 | 2.28e-06 | 195 | 121 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 3.38e-06 | 153 | 121 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 4.37e-06 | 112 | 121 | 7 | GO:1902476 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 6.91e-06 | 120 | 121 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 6.91e-06 | 120 | 121 | 7 | GO:0006835 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.06e-05 | 128 | 121 | 7 | GO:0006821 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.23e-05 | 87 | 121 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.23e-05 | 87 | 121 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.26e-05 | 183 | 121 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1M1 OR8D1 OR5M9 RAMP3 HTR2B HTR2C TAS1R3 OR13C8 GRM1 GRM3 OR5AR1 ITGB3 OR10J1 UCN2 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR TM2D1 OR52A1 | 1.85e-05 | 1395 | 121 | 22 | GO:0007186 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | HTR2C SLC38A9 SLC26A2 ARL6IP5 SLC13A3 GRM1 SLC10A7 SLC1A7 SLC11A1 ABCC2 SLC17A6 | 3.02e-05 | 410 | 121 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | HTR2C SLC38A9 SLC26A2 ARL6IP5 SLC13A3 GRM1 SLC10A7 SLC1A7 SLC11A1 ABCC2 SLC17A6 | 3.16e-05 | 412 | 121 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 4.23e-05 | 108 | 121 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | CYP2D6 HTR2C TCIRG1 BCAT2 TUNAR SNX19 UCN2 ADORA3 IGF1R SLC30A5 CLCN2 HSD17B6 LRP5 ABCC2 | 4.89e-05 | 684 | 121 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 5.02e-05 | 163 | 121 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 5.13e-05 | 35 | 121 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | sodium-dependent phosphate transport | 5.40e-05 | 13 | 121 | 3 | GO:0044341 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.86e-05 | 167 | 121 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | bicarbonate transport | 7.13e-05 | 38 | 121 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 7.98e-05 | 121 | 121 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast proliferation | 8.51e-05 | 15 | 121 | 3 | GO:0033690 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 8.69e-05 | 240 | 121 | 8 | GO:0070374 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 8.75e-05 | 40 | 121 | 4 | GO:0003161 | |
| GeneOntologyBiologicalProcess | heart process | 8.81e-05 | 309 | 121 | 9 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.02e-04 | 3 | 121 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | zinc ion import into Golgi lumen | 1.02e-04 | 3 | 121 | 2 | GO:1904257 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating serotonin receptor signaling pathway | 1.02e-04 | 3 | 121 | 2 | GO:0007208 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol biosynthetic process | 1.02e-04 | 3 | 121 | 2 | GO:0010513 | |
| GeneOntologyBiologicalProcess | circulatory system process | RAMP3 HTR2B HTR2C HCN4 SLC13A3 SLC4A3 ADORA3 SCN3A SCN4A SCN5A SCN8A LRP5 ABCC2 ATP2A3 | 1.02e-04 | 733 | 121 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1M1 OR8D1 OR5M9 TAS1R3 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 1.35e-04 | 485 | 121 | 11 | GO:0050907 |
| GeneOntologyBiologicalProcess | myeloid dendritic cell activation | 1.52e-04 | 46 | 121 | 4 | GO:0001773 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 1.52e-04 | 46 | 121 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1M1 OR8D1 OR5M9 TMC1 TAS1R3 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 1.63e-04 | 582 | 121 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | ATP6V0C RAMP3 HTR2B HTR2C SLAMF1 ITGB3 BTN2A1 CCR3 NOTCH1 NOTCH2 | 1.80e-04 | 418 | 121 | 10 | GO:0070371 |
| GeneOntologyBiologicalProcess | action potential | 1.86e-04 | 201 | 121 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | cytosol to Golgi apparatus transport | 2.03e-04 | 4 | 121 | 2 | GO:0140820 | |
| GeneOntologyBiologicalProcess | negative regulation of extracellular matrix constituent secretion | 2.03e-04 | 4 | 121 | 2 | GO:0003332 | |
| GeneOntologyBiologicalProcess | organic cation transport | 2.15e-04 | 145 | 121 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.20e-04 | 93 | 121 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 2.31e-04 | 94 | 121 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 2.34e-04 | 432 | 121 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | neurotransmitter uptake | 2.45e-04 | 52 | 121 | 4 | GO:0001504 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1M1 OR8D1 OR5M9 TAS1R3 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 2.64e-04 | 524 | 121 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 2.71e-04 | 359 | 121 | 9 | GO:0006874 | |
| GeneOntologyBiologicalProcess | optic nerve development | 2.80e-04 | 22 | 121 | 3 | GO:0021554 | |
| GeneOntologyBiologicalProcess | phosphate ion homeostasis | 3.20e-04 | 23 | 121 | 3 | GO:0055062 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 3.23e-04 | 101 | 121 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1M1 OR8D1 OR5M9 TMC1 CDHR2 TAS1R3 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 3.24e-04 | 722 | 121 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 3.37e-04 | 5 | 121 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol biosynthetic process | 3.37e-04 | 5 | 121 | 2 | GO:0010511 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 3.64e-04 | 24 | 121 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.79e-04 | 298 | 121 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR1M1 OR8D1 OR5M9 TAS1R3 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 3.80e-04 | 547 | 121 | 11 | GO:0007606 |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 4.04e-04 | 163 | 121 | 6 | GO:0002456 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 4.19e-04 | 465 | 121 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | cellular defense response | 4.26e-04 | 60 | 121 | 4 | GO:0006968 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 4.50e-04 | 385 | 121 | 9 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | HCN4 ARL6IP5 HCN3 GRM1 SLC4A3 SLC1A7 KCNC1 SCN3A SCN4A SCN5A SCN8A | 4.56e-04 | 559 | 121 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.79e-04 | 235 | 121 | 7 | GO:0002822 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 4.83e-04 | 62 | 121 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 4.85e-04 | 389 | 121 | 9 | GO:0055074 | |
| GeneOntologyBiologicalProcess | type II interferon production | 4.89e-04 | 169 | 121 | 6 | GO:0032609 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immunity | 4.99e-04 | 111 | 121 | 5 | GO:0002709 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.14e-04 | 63 | 121 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 5.42e-04 | 113 | 121 | 5 | GO:0000041 | |
| GeneOntologyBiologicalProcess | import into cell | RAMP3 HTR2B HCN4 ARL6IP5 GRM1 SLAMF1 ITGB3 SLC1A7 SLC39A12 SLC30A5 SLC11A1 CLCN2 MRC2 SCN5A LRP5 SLC17A6 | 5.43e-04 | 1074 | 121 | 16 | GO:0098657 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | ATP6V0C RAMP3 HTR2B HTR2C ARL6IP5 GRM1 SLAMF1 ITGB3 IGF1R NOTCH1 NOTCH2 | 5.44e-04 | 571 | 121 | 11 | GO:0043410 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 5.79e-04 | 65 | 121 | 4 | GO:0072348 | |
| GeneOntologyBiologicalProcess | zinc ion transmembrane transport | 6.44e-04 | 29 | 121 | 3 | GO:0071577 | |
| GeneOntologyBiologicalProcess | pH reduction | 7.03e-04 | 7 | 121 | 2 | GO:0045851 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic process involved in morphogenesis | 7.03e-04 | 7 | 121 | 2 | GO:1902339 | |
| GeneOntologyBiologicalProcess | regulation of pH | 7.12e-04 | 120 | 121 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | zinc ion transport | 7.12e-04 | 30 | 121 | 3 | GO:0006829 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 7.12e-04 | 30 | 121 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 7.24e-04 | 252 | 121 | 7 | GO:0002819 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 7.85e-04 | 31 | 121 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 7.85e-04 | 31 | 121 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 7.85e-04 | 31 | 121 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 8.63e-04 | 32 | 121 | 3 | GO:0060561 | |
| GeneOntologyCellularComponent | cell surface | IL13RA1 TMC1 RAMP3 LAYN HTR2C HLA-C SPN HLA-G PLXNB2 SLAMF1 ITGB3 SLC4A3 ITGB6 BTN2A1 SLC4A1 TSPAN33 KCNC1 MRC2 SCN5A CCR3 ABCC2 NOTCH1 NOTCH2 | 1.62e-07 | 1111 | 125 | 23 | GO:0009986 |
| GeneOntologyCellularComponent | membrane protein complex | IL13RA1 ATP6V0C RAMP3 HLA-C HCN4 SLC38A9 PIGS HCN3 HLA-G TCIRG1 GRM1 ITGB3 ITGB6 STT3A SLC4A1 TSPAN33 IGF1R CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A LRP5 SLC17A6 | 6.87e-07 | 1498 | 125 | 26 | GO:0098796 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.73e-06 | 17 | 125 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | receptor complex | IL13RA1 RAMP3 HTR2B HTR2C TAS1R3 GRM1 PLXNB2 ITGB3 ITGB6 IGF1R LRP5 TNFRSF1B NOTCH1 NOTCH2 | 1.01e-05 | 581 | 125 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | plasma membrane protein complex | IL13RA1 RAMP3 HLA-C HCN4 HCN3 HLA-G GRM1 ITGB3 ITGB6 IGF1R KCNC1 SCN3A SCN4A SCN5A SCN8A LRP5 | 1.84e-05 | 785 | 125 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | sodium channel complex | 2.58e-05 | 29 | 125 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYP2D6 HLA-C PIGS ARL6IP5 RNF19B HLA-G PMEL TUNAR SLC10A7 STT3A SLC30A7 SLC30A5 TMEM259 TMEM132A ABCC12 ZDHHC11 ATP2A3 NOTCH1 SMIM30 NOTCH2 JPH3 | 2.61e-05 | 1293 | 125 | 21 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYP2D6 HLA-C PIGS ARL6IP5 RNF19B HLA-G PMEL TUNAR SLC10A7 STT3A SLC30A7 SLC30A5 TMEM259 TMEM132A ABCC12 ZDHHC11 ATP2A3 NOTCH1 SMIM30 NOTCH2 JPH3 | 2.79e-05 | 1299 | 125 | 21 | GO:0098827 |
| GeneOntologyCellularComponent | secretory granule membrane | ATP6V0C HLA-C TCIRG1 ITGB3 SLC30A5 SLC11A1 CPNE3 CPNE1 TNFRSF1B PCDH7 | 2.92e-05 | 329 | 125 | 10 | GO:0030667 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CYP2D6 HLA-C PIGS ARL6IP5 RNF19B HLA-G PMEL TUNAR SLC10A7 STT3A SLC30A7 SLC30A5 TMEM259 TMEM132A ABCC12 ZDHHC11 ATP2A3 NOTCH1 SMIM30 NOTCH2 JPH3 | 3.81e-05 | 1327 | 125 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | phagocytic vesicle | 4.48e-05 | 157 | 125 | 7 | GO:0045335 | |
| GeneOntologyCellularComponent | external side of plasma membrane | IL13RA1 TMC1 HTR2C HLA-C SPN HLA-G SLAMF1 ITGB3 SLC4A3 ITGB6 BTN2A1 CCR3 | 6.70e-05 | 519 | 125 | 12 | GO:0009897 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ATP6V0C HCN4 HCN3 TCIRG1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 7.20e-05 | 523 | 125 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | microvillus membrane | 7.68e-05 | 38 | 125 | 4 | GO:0031528 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | HCN4 HCN3 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 9.31e-05 | 378 | 125 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | Golgi cis cisterna membrane | 1.06e-04 | 3 | 125 | 2 | GO:1990674 | |
| GeneOntologyCellularComponent | transporter complex | ATP6V0C HCN4 HCN3 TCIRG1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A SCN8A SLC17A6 | 1.16e-04 | 550 | 125 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 1.34e-04 | 17 | 125 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.41e-04 | 83 | 125 | 5 | GO:0030670 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.62e-04 | 135 | 125 | 6 | GO:0031985 | |
| GeneOntologyCellularComponent | apical plasma membrane | CDHR2 SLC26A2 TCIRG1 SLC34A2 SLC34A3 ITGB3 SLC30A5 CLCNKA ABCC2 SLC14A2 NOTCH1 | 1.67e-04 | 487 | 125 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | HCN channel complex | 2.11e-04 | 4 | 125 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | alphav-beta3 integrin-IGF-1-IGF1R complex | 2.11e-04 | 4 | 125 | 2 | GO:0035867 | |
| GeneOntologyCellularComponent | G protein-coupled serotonin receptor complex | 2.11e-04 | 4 | 125 | 2 | GO:0098666 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.72e-04 | 278 | 125 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | axon | HCN4 HCN3 TXNRD2 GRM1 GRM3 TENM2 SLC1A7 IGF1R KCNC1 SCN3A SCN4A SCN5A SCN8A TNFRSF1B SLC17A6 | 2.83e-04 | 891 | 125 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | Golgi medial cisterna | 3.39e-04 | 23 | 125 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | lysosomal membrane | ATP6V0C HLA-C SLC38A9 GDAP2 HLA-G TCIRG1 SLC11A1 SLC2A6 CPNE3 CPNE1 | 4.65e-04 | 462 | 125 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | ATP6V0C HLA-C SLC38A9 GDAP2 HLA-G TCIRG1 SLC11A1 SLC2A6 CPNE3 CPNE1 | 4.65e-04 | 462 | 125 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | cation channel complex | 5.38e-04 | 235 | 125 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | Golgi stack | 5.77e-04 | 171 | 125 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 7.30e-04 | 7 | 125 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | G protein-coupled receptor dimeric complex | 7.30e-04 | 7 | 125 | 2 | GO:0038037 | |
| GeneOntologyCellularComponent | side of membrane | IL13RA1 TMC1 HTR2C HLA-C SPN HLA-G SLAMF1 ITGB3 SLC4A3 ITGB6 BTN2A1 SLC4A1 CCR3 LYNX1 | 7.52e-04 | 875 | 125 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ATP6V0C HLA-C SLC38A9 HLA-G TCIRG1 PMEL ITGB3 SNX19 SLC30A5 SLC11A1 HSD17B6 CPNE3 CPNE1 TNFRSF1B ZDHHC11 PCDH7 NOTCH1 SLC17A6 | 7.71e-04 | 1307 | 125 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | apical part of cell | CDHR2 SLC26A2 TCIRG1 SLC34A2 SLC34A3 ITGB3 SLC30A5 CLCNKA ABCC2 SLC14A2 NOTCH1 | 8.62e-04 | 592 | 125 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | microvillus | 8.68e-04 | 123 | 125 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | vesicle membrane | ATP6V0C HLA-C SLC38A9 HLA-G TCIRG1 PMEL ITGB3 SNX19 SLC30A5 SLC11A1 HSD17B6 CPNE3 CPNE1 TNFRSF1B ZDHHC11 PCDH7 NOTCH1 SLC17A6 | 9.03e-04 | 1325 | 125 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | vacuolar membrane | ATP6V0C HLA-C SLC38A9 GDAP2 HLA-G TCIRG1 SLC11A1 SLC2A6 CPNE3 CPNE1 | 9.49e-04 | 507 | 125 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | endosome membrane | ATP6V0C HLA-C SLC38A9 HLA-G TCIRG1 PMEL SNX19 SLC11A1 HSD17B6 ZDHHC11 NOTCH1 | 9.87e-04 | 602 | 125 | 11 | GO:0010008 |
| GeneOntologyCellularComponent | lysosome | ATP6V0C RAMP3 HLA-C SLC38A9 GDAP2 RNF19B HLA-G TCIRG1 PLBD2 SLC11A1 SLC2A6 CPNE3 CPNE1 | 1.15e-03 | 811 | 125 | 13 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ATP6V0C RAMP3 HLA-C SLC38A9 GDAP2 RNF19B HLA-G TCIRG1 PLBD2 SLC11A1 SLC2A6 CPNE3 CPNE1 | 1.15e-03 | 811 | 125 | 13 | GO:0000323 |
| GeneOntologyCellularComponent | Golgi membrane | ATP6V0C HLA-C HLA-G SLC10A7 SLC30A7 FUT11 CASD1 SLC30A5 TMEM132A ZDHHC11 NOTCH1 NOTCH2 | 1.30e-03 | 721 | 125 | 12 | GO:0000139 |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase, V0 domain | 1.55e-03 | 10 | 125 | 2 | GO:0000220 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.55e-03 | 10 | 125 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | brush border membrane | 1.56e-03 | 83 | 125 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.70e-03 | 85 | 125 | 4 | GO:0005801 | |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 1.88e-03 | 11 | 125 | 2 | GO:0097648 | |
| GeneOntologyCellularComponent | dendrite | HTR2B HTR2C HCN4 HCN3 TXNRD2 GRM1 GRM3 TENM2 ADORA3 CLCN2 KCNC1 SCN8A LYNX1 | 1.90e-03 | 858 | 125 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | HTR2B HTR2C HCN4 HCN3 TXNRD2 GRM1 GRM3 TENM2 ADORA3 CLCN2 KCNC1 SCN8A LYNX1 | 1.94e-03 | 860 | 125 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase, V0 domain | 2.25e-03 | 12 | 125 | 2 | GO:0033179 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.47e-03 | 45 | 125 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | somatodendritic compartment | HTR2B HTR2C HCN4 HCN3 TXNRD2 GRM1 GRM3 TENM2 ADORA3 IGF1R CLCN2 KCNC1 SCN3A SCN8A LYNX1 TNFRSF1B | 2.69e-03 | 1228 | 125 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.04e-03 | 405 | 125 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 3.08e-03 | 14 | 125 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | vacuole | ATP6V0C RAMP3 HLA-C SLC38A9 GDAP2 RNF19B HLA-G TCIRG1 PLBD2 SLC11A1 SLC2A6 CPNE3 CPNE1 | 3.24e-03 | 913 | 125 | 13 | GO:0005773 |
| GeneOntologyCellularComponent | cell projection membrane | 4.42e-03 | 431 | 125 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | platelet alpha granule membrane | 4.55e-03 | 17 | 125 | 2 | GO:0031092 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.83e-03 | 57 | 125 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | sarcoplasm | 4.90e-03 | 114 | 125 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | azurophil granule membrane | 5.32e-03 | 59 | 125 | 3 | GO:0035577 | |
| GeneOntologyCellularComponent | anchoring junction | ATP6V0C LAYN CDHR2 ITGB3 TENM2 ITGB6 SLC4A1 TSPAN33 MRC2 SCN5A CPNE3 ABCC2 NOTCH1 | 5.66e-03 | 976 | 125 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 5.84e-03 | 61 | 125 | 3 | GO:0101003 | |
| GeneOntologyCellularComponent | presynaptic membrane | 6.47e-03 | 277 | 125 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 6.67e-03 | 64 | 125 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 6.77e-03 | 125 | 125 | 4 | GO:0140534 | |
| GeneOntologyCellularComponent | filopodium membrane | 6.92e-03 | 21 | 125 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.38e-03 | 384 | 125 | 7 | GO:0030139 | |
| GeneOntologyCellularComponent | synaptic membrane | 8.41e-03 | 583 | 125 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 8.99e-03 | 212 | 125 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | astrocyte projection | 9.73e-03 | 25 | 125 | 2 | GO:0097449 | |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase complex | 1.05e-02 | 26 | 125 | 2 | GO:0016471 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, proton-transporting domain | 1.05e-02 | 26 | 125 | 2 | GO:0033177 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.05e-02 | 26 | 125 | 2 | GO:0042611 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.10e-02 | 223 | 125 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | neuronal cell body | HTR2B HCN4 HCN3 TXNRD2 GRM1 IGF1R CLCN2 KCNC1 SCN3A SCN8A TNFRSF1B | 1.16e-02 | 835 | 125 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.26e-02 | 320 | 125 | 6 | GO:0016323 | |
| Domain | Na_channel_asu | 3.42e-07 | 10 | 121 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 3.42e-07 | 10 | 121 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 3.42e-07 | 10 | 121 | 4 | PF06512 | |
| Domain | Na_trans_cytopl | 5.23e-06 | 6 | 121 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 5.23e-06 | 6 | 121 | 3 | IPR024583 | |
| Domain | Ion_trans_dom | 9.33e-06 | 114 | 121 | 7 | IPR005821 | |
| Domain | Ion_trans | 9.33e-06 | 114 | 121 | 7 | PF00520 | |
| Domain | GPCR_Rhodpsn_7TM | OR1M1 OR8D1 OR5M9 HTR2B HTR2C OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR OR52A1 | 2.86e-05 | 670 | 121 | 15 | IPR017452 |
| Domain | 7tm_1 | OR1M1 OR8D1 OR5M9 HTR2B HTR2C OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR OR52A1 | 3.22e-05 | 677 | 121 | 15 | PF00001 |
| Domain | Channel_four-helix_dom | 3.36e-05 | 57 | 121 | 5 | IPR027359 | |
| Domain | - | 3.36e-05 | 57 | 121 | 5 | 1.20.120.350 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1M1 OR8D1 OR5M9 HTR2B HTR2C OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR OR52A1 | 3.68e-05 | 685 | 121 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1M1 OR8D1 OR5M9 HTR2B HTR2C OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR OR52A1 | 4.07e-05 | 691 | 121 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1M1 OR8D1 OR5M9 HTR2B HTR2C OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 ADORA3 CCR3 NMBR OR52A1 | 4.14e-05 | 692 | 121 | 15 | IPR000276 |
| Domain | NCD3G | 7.23e-05 | 13 | 121 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 7.23e-05 | 13 | 121 | 3 | IPR011500 | |
| Domain | GPCR_3_CS | 9.16e-05 | 14 | 121 | 3 | IPR017979 | |
| Domain | Na/Pi_transpt | 1.24e-04 | 3 | 121 | 2 | IPR003841 | |
| Domain | DUF3454 | 1.24e-04 | 3 | 121 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.24e-04 | 3 | 121 | 2 | IPR024600 | |
| Domain | Anion_exchange_CS | 1.24e-04 | 3 | 121 | 2 | IPR018241 | |
| Domain | Na_Pi_cotrans | 1.24e-04 | 3 | 121 | 2 | PF02690 | |
| Domain | DUF3454 | 1.24e-04 | 3 | 121 | 2 | SM01334 | |
| Domain | Olfact_rcpt | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 2.41e-04 | 393 | 121 | 10 | IPR000725 |
| Domain | Notch | 2.48e-04 | 4 | 121 | 2 | IPR008297 | |
| Domain | NODP | 2.48e-04 | 4 | 121 | 2 | PF07684 | |
| Domain | Ion_trans_N | 2.48e-04 | 4 | 121 | 2 | PF08412 | |
| Domain | Ion_trans_N | 2.48e-04 | 4 | 121 | 2 | IPR013621 | |
| Domain | Notch_NODP_dom | 2.48e-04 | 4 | 121 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.48e-04 | 4 | 121 | 2 | IPR010660 | |
| Domain | NOD | 2.48e-04 | 4 | 121 | 2 | PF06816 | |
| Domain | - | 2.48e-04 | 4 | 121 | 2 | 1.20.5.630 | |
| Domain | NOD | 2.48e-04 | 4 | 121 | 2 | SM01338 | |
| Domain | NODP | 2.48e-04 | 4 | 121 | 2 | SM01339 | |
| Domain | GPCR_3 | 3.24e-04 | 21 | 121 | 3 | IPR000337 | |
| Domain | 7tm_3 | 3.73e-04 | 22 | 121 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.73e-04 | 22 | 121 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.73e-04 | 22 | 121 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.73e-04 | 22 | 121 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.73e-04 | 22 | 121 | 3 | PS50259 | |
| Domain | GPCR_3_C | 3.73e-04 | 22 | 121 | 3 | IPR017978 | |
| Domain | Na/sul_symport | 4.11e-04 | 5 | 121 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 4.11e-04 | 5 | 121 | 2 | PF00939 | |
| Domain | Anion_exchange | 4.11e-04 | 5 | 121 | 2 | IPR001717 | |
| Domain | LNR | 4.11e-04 | 5 | 121 | 2 | PS50258 | |
| Domain | Integrin_bsu_cyt_dom | 6.14e-04 | 6 | 121 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 6.14e-04 | 6 | 121 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 6.14e-04 | 6 | 121 | 2 | PF08725 | |
| Domain | 7TM_GPCR_Srsx | 8.11e-04 | 112 | 121 | 5 | SM01381 | |
| Domain | ANION_EXCHANGER_2 | 8.56e-04 | 7 | 121 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 8.56e-04 | 7 | 121 | 2 | PS00219 | |
| Domain | Integrin_bsu_tail | 8.56e-04 | 7 | 121 | 2 | IPR012896 | |
| Domain | Notch_dom | 8.56e-04 | 7 | 121 | 2 | IPR000800 | |
| Domain | Notch | 8.56e-04 | 7 | 121 | 2 | PF00066 | |
| Domain | Integrin_B_tail | 8.56e-04 | 7 | 121 | 2 | SM01242 | |
| Domain | NL | 8.56e-04 | 7 | 121 | 2 | SM00004 | |
| Domain | Integrin_B_tail | 8.56e-04 | 7 | 121 | 2 | PF07965 | |
| Domain | Integrin_beta | 1.14e-03 | 8 | 121 | 2 | PF00362 | |
| Domain | INB | 1.14e-03 | 8 | 121 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 1.14e-03 | 8 | 121 | 2 | IPR002369 | |
| Domain | GPCR_3_mtglu_rcpt | 1.14e-03 | 8 | 121 | 2 | IPR000162 | |
| Domain | Cyclin_L/T | 1.14e-03 | 8 | 121 | 2 | IPR015429 | |
| Domain | Copine | 1.45e-03 | 9 | 121 | 2 | PF07002 | |
| Domain | Cl-channel_core | 1.45e-03 | 9 | 121 | 2 | IPR014743 | |
| Domain | Integrin_bsu | 1.45e-03 | 9 | 121 | 2 | IPR015812 | |
| Domain | Band3_cytoplasmic_dom | 1.45e-03 | 9 | 121 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.45e-03 | 9 | 121 | 2 | PF07565 | |
| Domain | - | 1.45e-03 | 9 | 121 | 2 | 3.40.1100.10 | |
| Domain | - | 1.45e-03 | 9 | 121 | 2 | 1.10.3080.10 | |
| Domain | Integin_beta_N | 1.45e-03 | 9 | 121 | 2 | IPR033760 | |
| Domain | Voltage_CLC | 1.45e-03 | 9 | 121 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.45e-03 | 9 | 121 | 2 | IPR001807 | |
| Domain | Copine | 1.45e-03 | 9 | 121 | 2 | IPR010734 | |
| Domain | INTEGRIN_BETA | 1.45e-03 | 9 | 121 | 2 | PS00243 | |
| Domain | PSI_integrin | 1.45e-03 | 9 | 121 | 2 | PF17205 | |
| Domain | 5HT_rcpt | 1.45e-03 | 9 | 121 | 2 | IPR002231 | |
| Domain | ANF_lig-bd_rcpt | 1.75e-03 | 37 | 121 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.75e-03 | 37 | 121 | 3 | PF01094 | |
| Domain | Cation_efflux | 1.81e-03 | 10 | 121 | 2 | IPR002524 | |
| Domain | HCO3_cotransp | 1.81e-03 | 10 | 121 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.81e-03 | 10 | 121 | 2 | IPR011531 | |
| Domain | E3_UB_ligase_RBR | 1.81e-03 | 10 | 121 | 2 | IPR031127 | |
| Domain | Cation_efflux | 1.81e-03 | 10 | 121 | 2 | PF01545 | |
| Domain | PTrfase/Anion_transptr | 1.81e-03 | 10 | 121 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.81e-03 | 10 | 121 | 2 | IPR003020 | |
| Domain | IQ | 1.90e-03 | 81 | 121 | 4 | SM00015 | |
| Domain | VWFA | 1.99e-03 | 82 | 121 | 4 | PS50234 | |
| Domain | Peripla_BP_I | 2.04e-03 | 39 | 121 | 3 | IPR028082 | |
| Domain | VWA | 2.17e-03 | 84 | 121 | 4 | SM00327 | |
| Domain | - | 2.20e-03 | 11 | 121 | 2 | 1.20.1510.10 | |
| Domain | Cation_efflux_TMD | 2.20e-03 | 11 | 121 | 2 | IPR027469 | |
| Domain | Cyclin-like | 2.71e-03 | 43 | 121 | 3 | IPR013763 | |
| Domain | IQ_motif_EF-hand-BS | 2.79e-03 | 90 | 121 | 4 | IPR000048 | |
| Domain | PSI | 2.89e-03 | 44 | 121 | 3 | IPR016201 | |
| Domain | IQ | 3.14e-03 | 93 | 121 | 4 | PS50096 | |
| Domain | PSI | 3.29e-03 | 46 | 121 | 3 | SM00423 | |
| Domain | PLAC | 3.60e-03 | 14 | 121 | 2 | PF08686 | |
| Domain | IBR | 3.60e-03 | 14 | 121 | 2 | SM00647 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 3.60e-03 | 14 | 121 | 2 | IPR003938 | |
| Domain | EamA_dom | 3.60e-03 | 14 | 121 | 2 | IPR000620 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A2 SLC34A2 SLC13A3 SLC34A3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 SLC30A5 SLC11A1 SLC2A6 SLC14A2 SLC17A6 | 1.43e-08 | 238 | 101 | 13 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC26A2 SLC34A2 SLC13A3 SLC34A3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 SLC30A5 SLC11A1 SLC2A6 SLC14A2 SLC17A6 | 2.45e-08 | 249 | 101 | 13 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V0C SLC26A2 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 SLC30A5 SLC11A1 CLCN2 CLCNKA SLC2A6 ABCC2 ATP2A3 SLC14A2 SLC17A6 | 6.07e-08 | 681 | 101 | 20 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V0C SLC26A2 TCIRG1 SLC34A2 SLC13A3 SLC34A3 NIPAL3 SLC4A3 SLC1A7 SLC4A1 SLC13A4 SLC30A5 SLC11A1 CLCN2 CLCNKA SLC2A6 ABCC2 ATP2A3 SLC14A2 SLC17A6 | 2.14e-07 | 736 | 101 | 20 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.21e-05 | 108 | 101 | 7 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.29e-05 | 109 | 101 | 7 | MM15074 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1M1 OR8D1 OR5M9 TMC1 TAS1R3 OR13C8 GRM1 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 HSD17B6 SCN3A OR52A1 | 4.48e-05 | 636 | 101 | 15 | M41834 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 6.73e-05 | 31 | 101 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 7.65e-05 | 32 | 101 | 4 | M27455 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.11e-04 | 76 | 101 | 5 | MM15072 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.69e-04 | 18 | 101 | 3 | M614 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.37e-04 | 84 | 101 | 5 | M27334 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 5.01e-04 | 5 | 101 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 5.01e-04 | 5 | 101 | 2 | M27345 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 5.01e-04 | 5 | 101 | 2 | M27354 | |
| Pathway | REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS | 5.01e-04 | 5 | 101 | 2 | MM15085 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 5.01e-04 | 5 | 101 | 2 | M27411 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 7.33e-04 | 57 | 101 | 4 | M39812 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 7.48e-04 | 6 | 101 | 2 | M47468 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 7.48e-04 | 6 | 101 | 2 | M27068 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 8.04e-04 | 417 | 101 | 10 | M4072 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.02e-03 | 430 | 101 | 10 | MM15160 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.04e-03 | 7 | 101 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.04e-03 | 7 | 101 | 2 | M47530 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.26e-03 | 367 | 101 | 9 | M48346 | |
| Pubmed | 7.93e-10 | 5 | 125 | 4 | 17724025 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.07e-09 | 139 | 125 | 9 | 16985003 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | IL13RA1 HLA-C RNF19A SLC26A2 PIGS HLA-G TCIRG1 STT3A SLC35F5 MED24 SLC30A5 SLC2A6 MRC2 BAMBI MMP15 ATP2A3 BAG6 NOTCH1 NOTCH2 | 8.70e-09 | 1061 | 125 | 19 | 33845483 |
| Pubmed | 1.98e-08 | 9 | 125 | 4 | 16382098 | ||
| Pubmed | 1.98e-08 | 9 | 125 | 4 | 15746173 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | ATP6V0C HTR2B HTR2C HLA-C ARL6IP5 GRM1 DHRS1 SLC4A3 TSPAN33 CD82 TMEM259 SLC2A6 ZDHHC11 NOTCH2 JPH3 | 3.45e-08 | 697 | 125 | 15 | 28298427 |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 4.51e-07 | 5 | 125 | 3 | 22875929 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HLA-C PIGS DCBLD1 PLXNB2 PLBD2 BTN2A1 STT3A SLC30A7 IGF1R TMEM259 MRC2 TMEM132A LRP5 ATP2A3 PCDH7 NOTCH1 NOTCH2 | 1.51e-06 | 1201 | 125 | 17 | 35696571 |
| Pubmed | HLA-C SLC26A2 PIGS ARL6IP5 BCAT2 SNX19 SLC30A7 SLC30A5 PCDH7 BAG6 NOTCH2 | 2.23e-06 | 504 | 125 | 11 | 34432599 | |
| Pubmed | Chromosomal location of the murine anion exchanger genes encoding AE2 and AE3. | 2.50e-06 | 8 | 125 | 3 | 7894173 | |
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 5.17e-06 | 69 | 125 | 5 | 26792178 | |
| Pubmed | 5.34e-06 | 10 | 125 | 3 | 17156446 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 9.74e-06 | 12 | 125 | 3 | 30175250 | |
| Pubmed | 1.26e-05 | 13 | 125 | 3 | 15123669 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26168276 | ||
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 1.28e-05 | 2 | 125 | 2 | 24508387 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 1.28e-05 | 2 | 125 | 2 | 23380742 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21466361 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20069650 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15625786 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20154720 | ||
| Pubmed | Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. | 1.28e-05 | 2 | 125 | 2 | 17261636 | |
| Pubmed | Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. | 1.28e-05 | 2 | 125 | 2 | 8440332 | |
| Pubmed | Differential expression of Notch1 and Notch2 in developing and adult mouse brain. | 1.28e-05 | 2 | 125 | 2 | 7609614 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33017398 | ||
| Pubmed | Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. | 1.28e-05 | 2 | 125 | 2 | 21285514 | |
| Pubmed | Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. | 1.28e-05 | 2 | 125 | 2 | 18353145 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22205705 | ||
| Pubmed | Notch signaling induces cell cycle arrest in small cell lung cancer cells. | 1.28e-05 | 2 | 125 | 2 | 11306509 | |
| Pubmed | Correlation of asymmetric Notch2 expression and mouse incisor rotation. | 1.28e-05 | 2 | 125 | 2 | 10704869 | |
| Pubmed | Notch signaling is necessary but not sufficient for differentiation of dendritic cells. | 1.28e-05 | 2 | 125 | 2 | 12907456 | |
| Pubmed | Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. | 1.28e-05 | 2 | 125 | 2 | 12054167 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34513312 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33237915 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23589286 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11834499 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 8917536 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38492472 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15525635 | ||
| Pubmed | Functional conservation of Notch1 and Notch2 intracellular domains. | 1.28e-05 | 2 | 125 | 2 | 15897231 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30296524 | ||
| Pubmed | Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. | 1.28e-05 | 2 | 125 | 2 | 12753746 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26041884 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24628914 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23228395 | ||
| Pubmed | Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women. | 1.28e-05 | 2 | 125 | 2 | 18418639 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12970106 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25786252 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15492845 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29643502 | ||
| Pubmed | Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro. | 1.28e-05 | 2 | 125 | 2 | 31316119 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23275032 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11535235 | ||
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 1.28e-05 | 2 | 125 | 2 | 17652726 | |
| Pubmed | Promoter-sharing by different genes in human genome--CPNE1 and RBM12 gene pair as an example. | 1.28e-05 | 2 | 125 | 2 | 18831769 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25367742 | ||
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 1.28e-05 | 2 | 125 | 2 | 25041344 | |
| Pubmed | Receptor-binding domain of SARS-CoV-2 is a functional αv-integrin agonist. | 1.28e-05 | 2 | 125 | 2 | 36669646 | |
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 1.28e-05 | 2 | 125 | 2 | 25866967 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32423029 | ||
| Pubmed | Notch2 signaling is required for potent antitumor immunity in vivo. | 1.28e-05 | 2 | 125 | 2 | 20351182 | |
| Pubmed | Involvement of Notch in activation and effector functions of γδ T cells. | 1.28e-05 | 2 | 125 | 2 | 24489102 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22275271 | ||
| Pubmed | The Notch pathway in podocytes plays a role in the development of glomerular disease. | 1.28e-05 | 2 | 125 | 2 | 18311147 | |
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 1.28e-05 | 2 | 125 | 2 | 30944319 | |
| Pubmed | Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. | 1.28e-05 | 2 | 125 | 2 | 25141821 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21807868 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23453247 | ||
| Pubmed | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. | 1.28e-05 | 2 | 125 | 2 | 26933171 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21693515 | ||
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 1.28e-05 | 2 | 125 | 2 | 27779234 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20846463 | ||
| Pubmed | New mouse 5-HT2-like receptor. Expression in brain, heart and intestine. | 1.28e-05 | 2 | 125 | 2 | 1426253 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 20124171 | ||
| Pubmed | Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis. | 1.28e-05 | 2 | 125 | 2 | 27564686 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25982147 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19701457 | ||
| Pubmed | Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. | 1.28e-05 | 2 | 125 | 2 | 28820917 | |
| Pubmed | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. | 1.28e-05 | 2 | 125 | 2 | 22006338 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19339697 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19915064 | ||
| Pubmed | Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. | 1.28e-05 | 2 | 125 | 2 | 27776108 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16636052 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18666240 | ||
| Pubmed | In vivo mapping of notch pathway activity in normal and stress hematopoiesis. | 1.28e-05 | 2 | 125 | 2 | 23791481 | |
| Pubmed | 1.36e-05 | 84 | 125 | 5 | 15123239 | ||
| Pubmed | 1.60e-05 | 14 | 125 | 3 | 9021146 | ||
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 1.60e-05 | 14 | 125 | 3 | 29107716 | |
| Pubmed | 2.35e-05 | 94 | 125 | 5 | 32062451 | ||
| Pubmed | OR1M1 OR8D1 OR5M9 OR13C8 OR5AR1 OR10J1 OR4K14 OR8B3 OR52J3 OR52A1 | 2.74e-05 | 541 | 125 | 10 | 14983052 | |
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 3.33e-05 | 101 | 125 | 5 | 20587610 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.33e-05 | 101 | 125 | 5 | 23382219 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 3.35e-05 | 340 | 125 | 8 | 11875048 | |
| Pubmed | 3.35e-05 | 340 | 125 | 8 | 11802173 | ||
| Pubmed | 3.56e-05 | 18 | 125 | 3 | 37321992 | ||
| Pubmed | 3.57e-05 | 343 | 125 | 8 | 32295537 | ||
| Pubmed | 3.79e-05 | 346 | 125 | 8 | 14611657 | ||
| Pubmed | 3.84e-05 | 3 | 125 | 2 | 11994299 | ||
| Pubmed | NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells. | 3.84e-05 | 3 | 125 | 2 | 24122995 | |
| Pubmed | Serotonin 2C receptor contributes to gender differences in stress-induced hypophagia in aged mice. | 3.84e-05 | 3 | 125 | 2 | 25732068 | |
| Interaction | B3GNT3 interactions | 6.30e-07 | 85 | 117 | 7 | int:B3GNT3 | |
| Interaction | SNTA1 interactions | 2.64e-06 | 105 | 117 | 7 | int:SNTA1 | |
| Interaction | TCIRG1 interactions | 3.85e-06 | 72 | 117 | 6 | int:TCIRG1 | |
| Interaction | CASR interactions | 7.28e-06 | 22 | 117 | 4 | int:CASR | |
| Interaction | GPR173 interactions | 1.15e-05 | 51 | 117 | 5 | int:GPR173 | |
| Interaction | CLEC2B interactions | 2.42e-05 | 147 | 117 | 7 | int:CLEC2B | |
| Interaction | GPX8 interactions | RAMP3 HLA-C HLA-G SLC13A3 SLC34A3 NIPAL3 TSPAN33 SLC39A12 ATP2A3 | 3.11e-05 | 273 | 117 | 9 | int:GPX8 |
| Interaction | C5AR1 interactions | 3.26e-05 | 154 | 117 | 7 | int:C5AR1 | |
| Interaction | KLK5 interactions | 4.19e-05 | 109 | 117 | 6 | int:KLK5 | |
| Interaction | CLPSL1 interactions | 5.23e-05 | 13 | 117 | 3 | int:CLPSL1 | |
| Interaction | NCR3 interactions | 7.18e-05 | 120 | 117 | 6 | int:NCR3 | |
| Interaction | TMED6 interactions | 7.59e-05 | 39 | 117 | 4 | int:TMED6 | |
| Interaction | IL5RA interactions | 8.61e-05 | 124 | 117 | 6 | int:IL5RA | |
| Interaction | DPY19L4 interactions | 1.12e-04 | 43 | 117 | 4 | int:DPY19L4 | |
| Interaction | ST8SIA4 interactions | 1.30e-04 | 84 | 117 | 5 | int:ST8SIA4 | |
| Interaction | LGALS1 interactions | 1.39e-04 | 332 | 117 | 9 | int:LGALS1 | |
| Interaction | SIRPD interactions | 1.45e-04 | 86 | 117 | 5 | int:SIRPD | |
| Interaction | S1PR4 interactions | 1.49e-04 | 137 | 117 | 6 | int:S1PR4 | |
| Interaction | ATP6V0C interactions | 1.49e-04 | 137 | 117 | 6 | int:ATP6V0C | |
| Interaction | FAM241B interactions | 1.80e-04 | 90 | 117 | 5 | int:FAM241B | |
| Interaction | SCN8A interactions | 2.02e-04 | 20 | 117 | 3 | int:SCN8A | |
| GeneFamily | Solute carriers | SLC38A9 SLC26A2 SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC4A3 SLC1A7 SLC4A1 SLC35F5 SLC30A7 SLC39A12 SLC13A4 SLC30A5 SLC11A1 SLC35F3 SLC2A6 SLC14A2 SLC17A6 | 2.42e-12 | 395 | 109 | 19 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.54e-07 | 9 | 109 | 4 | 1203 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL13RA1 SPN SLAMF1 ITGB3 SLC4A1 CD82 IGF1R MRC2 CCR3 TNFRSF1B | 1.35e-04 | 394 | 109 | 10 | 471 |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 9.85e-04 | 8 | 109 | 2 | 281 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.26e-03 | 9 | 109 | 2 | 1159 | |
| GeneFamily | Copines | 1.26e-03 | 9 | 109 | 2 | 829 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.57e-03 | 10 | 109 | 2 | 250 | |
| GeneFamily | Chloride voltage-gated channels | 1.57e-03 | 10 | 109 | 2 | 302 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 2.69e-03 | 13 | 109 | 2 | 170 | |
| GeneFamily | ATP binding cassette subfamily C | 2.69e-03 | 13 | 109 | 2 | 807 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 5.76e-03 | 19 | 109 | 2 | 50 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.51e-06 | 198 | 123 | 8 | MM17083 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | LAYN HLA-C PIGS HLA-G DCBLD1 PLXNB2 STT3A SLC30A7 IGF1R SLC30A5 TMEM259 MRC2 TNFRSF1B | 2.73e-05 | 703 | 123 | 13 | MM1055 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | OR8D1 CYP2D6 HTR2C ESRRA SLC13A3 GRM1 GRM3 ITGB3 SLC4A3 ADORA3 TMEM171 IGF1R SERPINI2 CLCNKA SCN3A ATP2A3 BAG6 NOTCH1 | 3.01e-05 | 1281 | 123 | 18 | M1884 |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 4.42e-05 | 199 | 123 | 7 | M3440 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN | 4.56e-05 | 200 | 123 | 7 | M8647 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 4.56e-05 | 200 | 123 | 7 | M6237 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 4.56e-05 | 200 | 123 | 7 | M8690 | |
| Coexpression | NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP | 5.42e-05 | 44 | 123 | 4 | M40896 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_UP | 6.04e-05 | 284 | 123 | 8 | M19993 | |
| Coexpression | BAUS_TFF2_TARGETS_UP | 8.31e-05 | 49 | 123 | 4 | MM1287 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 9.56e-05 | 225 | 123 | 7 | MM17079 | |
| Coexpression | HAY_BONE_MARROW_MONOCYTE | 9.83e-05 | 226 | 123 | 7 | M39201 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-08 | 161 | 124 | 8 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 8.04e-08 | 196 | 124 | 8 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.04e-08 | 196 | 124 | 8 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.39e-08 | 200 | 124 | 8 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-07 | 168 | 124 | 7 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 1.27e-06 | 195 | 124 | 7 | 88d65c7c3a28922c125bd9f7c403a55d7d4d83a9 | |
| ToppCell | myeloid-CD16+_Monocyte|World / Lineage and Cell class | 1.31e-06 | 196 | 124 | 7 | 225c102e0a2047425a7125eba1d2359159c50409 | |
| ToppCell | (001)_CD16+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 1.31e-06 | 196 | 124 | 7 | 33843d550cbca03c044d593b1f6972e4d3871f7f | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.35e-06 | 197 | 124 | 7 | 368644260f70895052a1d71171a9d882315354dd | |
| ToppCell | COVID-19_Severe-Myeloid-Non-classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class | 1.35e-06 | 197 | 124 | 7 | c5837b9a5a39a0f607a4e217ade9fc87d82a5406 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.35e-06 | 197 | 124 | 7 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-CD16+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class | 1.50e-06 | 200 | 124 | 7 | 58fbb7fc7159cbc417e6b457d60b7beba9b90da6 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-06 | 200 | 124 | 7 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | severe-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.50e-06 | 200 | 124 | 7 | 804c6e998fb7a29ca1b98f53d5dbcb7ae5a47e7a | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 153 | 124 | 6 | 6dcab3d50ab50051955204dc4e4a64c1ca855bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 153 | 124 | 6 | f6ef14d949107c08cb3690e26ec91e194cb43518 | |
| ToppCell | Myeloid-F|World / shred on cell class and cell subclass (v4) | 4.67e-06 | 154 | 124 | 6 | 6d53eec4aefe54836bbfd314f28f5e9a24c2d833 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.03e-06 | 156 | 124 | 6 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.03e-06 | 156 | 124 | 6 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-06 | 158 | 124 | 6 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.82e-06 | 160 | 124 | 6 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.47e-06 | 163 | 124 | 6 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.70e-06 | 164 | 124 | 6 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 164 | 124 | 6 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 164 | 124 | 6 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-06 | 165 | 124 | 6 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-06 | 168 | 124 | 6 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-06 | 168 | 124 | 6 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-06 | 168 | 124 | 6 | f3b7a7df54988de77dcc7066e2fc1feb9c280b13 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-06 | 168 | 124 | 6 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-06 | 168 | 124 | 6 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.69e-06 | 168 | 124 | 6 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-06 | 170 | 124 | 6 | 7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-06 | 170 | 124 | 6 | db7cee7e518debb2cbe9eeae05d47e14b69cb8e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 183 | 124 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 1.59e-05 | 191 | 124 | 6 | 44a797b39254cbfa5c2bad8155436adfd3019bb0 | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|Influenza_Severe / Disease group and Cell class | 1.59e-05 | 191 | 124 | 6 | 197edf6feb1cfc71d88e532d74f77305a42a3486 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 191 | 124 | 6 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 191 | 124 | 6 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.64e-05 | 192 | 124 | 6 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.74e-05 | 194 | 124 | 6 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.74e-05 | 194 | 124 | 6 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|severe_influenza / disease group, cell group and cell class (v2) | 1.74e-05 | 194 | 124 | 6 | 7630e223666fb65743e21e045478f687dd739a54 | |
| ToppCell | myeloid-CD16+_Monocyte|myeloid / Lineage and Cell class | 1.74e-05 | 194 | 124 | 6 | aeeadfeb01827dbc7de6576c76fb2e41a3c59247 | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.74e-05 | 194 | 124 | 6 | 28d19105123b015f8aa25ea8e6c078f630d4ba80 | |
| ToppCell | IIF-Myeloid-CD16_Mono|IIF / Disease, Lineage and Cell Type | 1.79e-05 | 195 | 124 | 6 | 87c1f52ab19b105bae3f315496c620c226a77a7f | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.85e-05 | 196 | 124 | 6 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 1.85e-05 | 196 | 124 | 6 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 1.85e-05 | 196 | 124 | 6 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 1.85e-05 | 196 | 124 | 6 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | control-Non-classical_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.85e-05 | 196 | 124 | 6 | 1d71a5be652dd3281aba4f984f6ef84c993c5f63 | |
| ToppCell | BLOOD--(3)_Non_classical_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.85e-05 | 196 | 124 | 6 | b5ce99e27c9e87be52c10c022a665bf4df0e8b05 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 196 | 124 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | Multiple_Sclerosis-Myeloid-CD16_Mono|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.85e-05 | 196 | 124 | 6 | 83011b56780295dff5ded57064b07dcd2f19ea26 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-05 | 197 | 124 | 6 | 083fec147040ee0bebac2815fb89355cf3a7ffa5 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 197 | 124 | 6 | f0e6745b0fd734ea17e7a2a883e48017e8d3102d | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 1.90e-05 | 197 | 124 | 6 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-05 | 197 | 124 | 6 | 1463522df1b6358cbe3b5022a3e153878e9c9e43 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-05 | 197 | 124 | 6 | 46d8c7e9b3aff70bc58894282d0ec9e87d37235f | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-05 | 197 | 124 | 6 | b82142cf8057a55dfa884248b752173661edffd1 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 197 | 124 | 6 | 96d56bce69de7192c7a6b43371b56f4acdcc7733 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-05 | 197 | 124 | 6 | 1a82e0e74fc5fd71c490d98e8813d719b0b81aa6 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-05 | 197 | 124 | 6 | 70faaea9c143337a52c8f660ebb063aa92327357 | |
| ToppCell | PBMC-Mild-Myeloid-Non-classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 197 | 124 | 6 | 422074930fce25a6ad15ba41e391c65787e7878e | |
| ToppCell | COVID-19_Mild-Myeloid-Non-classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class | 1.90e-05 | 197 | 124 | 6 | 9c943d18f8e6cb0ce9f2158d50796fafae5c81d4 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | 9b8679b3dd8f4220d71f607b7080cb88d6e71129 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | 8b6b602ebe59b6dca6a22f17385d3160ff3ac67e | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 198 | 124 | 6 | d91bd26e499637949768587603cad3c03dcc56e7 | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 1.95e-05 | 198 | 124 | 6 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 198 | 124 | 6 | 8de49c62ab533031936db4cee50ff13b259ecc22 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | b9030390316baf456135f85f831394e1e11ecf3e | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 198 | 124 | 6 | f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 198 | 124 | 6 | 60e5bd8dfe27c43ce5f4da19b65270c41577ef4f | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | d36a3cda7e5f385d2391e9b0dfb027d3c4549320 | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 1.95e-05 | 198 | 124 | 6 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 5436c3ed16e10e00c686f1ab0b0a68728a1a9985 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.95e-05 | 198 | 124 | 6 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-non-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-05 | 198 | 124 | 6 | 11b0d021114df73a539b04f76dd7c63f1fdbdf4f | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| ToppCell | Control-Myeloid-Non-classical_Monocyte|Control / Disease group, lineage and cell class | 1.95e-05 | 198 | 124 | 6 | ae0a51e63e2751a6d9dc0c8a3852680949173523 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | 7d8fade2583c07a33dd83057cbce08e9fc77987a | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.95e-05 | 198 | 124 | 6 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 1.95e-05 | 198 | 124 | 6 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | PBMC-Severe-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 4f67067d8142ca11b2d80195dac8d62a8d24d52c | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 198 | 124 | 6 | 165d60b111a17d517a420c434733eefb98da240d | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.01e-05 | 199 | 124 | 6 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | 99eec995aa20ac22a8dd045382bd15a15db0b87a | |
| ToppCell | Healthy/Control-Classical_Monocyte|World / Disease group and Cell class | 2.01e-05 | 199 | 124 | 6 | 527c767a09f911e319f7ad230b6518cebc0f367d | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 199 | 124 | 6 | aca9f75c690c6ed952bcbdc7e1e7eef7719f54ca | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | 3e09b3c2e2c57e5248981293020d2434e898e3e1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 199 | 124 | 6 | 0a9783808528bc4c6d797d849a9177330c8fb867 | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.01e-05 | 199 | 124 | 6 | ae6b4b4557c6a9223acdee2a79bc780c5916d38a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 199 | 124 | 6 | 87c7b8c77c28f3cfa6d6dddfd00c9d18d116207e | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 199 | 124 | 6 | 4eed28ef8c74d7131eeeabdd732a682d91e034dd | |
| ToppCell | PBMC-Convalescent-Myeloid-Non-classical_Monocyte|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | f234533254fd82b1ef2041e8405fe201d874018b | |
| ToppCell | COVID-19_Convalescent-Myeloid-Non-classical_Monocyte|COVID-19_Convalescent / Disease group, lineage and cell class | 2.01e-05 | 199 | 124 | 6 | 5253948a1d7fc3da571860e14cdde4e18222e13b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 199 | 124 | 6 | 6d439c0c5e6b72fcb8d4dc72e7445eb6a01fe095 | |
| Computational | Genes in the cancer module 27. | IL13RA1 RAMP3 HTR2B HLA-C HLA-G GRM3 SLAMF1 ITGB3 ITGB6 ADORA3 TNFRSF1B | 2.48e-05 | 355 | 73 | 11 | MODULE_27 |
| Drug | sodium | SLC26A2 ARL6IP5 TCIRG1 SLC34A2 SLC13A3 SLC34A3 SLC10A7 SLC4A3 PLBD2 SLC1A7 SLC4A1 SLC13A4 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A ABCC2 ATP2A3 SLC14A2 SLC17A6 | 1.67e-09 | 944 | 125 | 23 | CID000000923 |
| Drug | thioxanthene | 1.77e-07 | 10 | 125 | 4 | CID000067495 | |
| Drug | Sodium | 4.05e-07 | 84 | 125 | 7 | ctd:D012964 | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.28e-06 | 194 | 125 | 9 | 4182_UP | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 2.28e-06 | 39 | 125 | 5 | CID003331970 | |
| Drug | piperazine | 3.06e-06 | 73 | 125 | 6 | CID000004837 | |
| Drug | APETx1, Anthopleura elegantissima | 3.19e-06 | 6 | 125 | 3 | ctd:C475726 | |
| Drug | chloride | HTR2B HTR2C SLC26A2 TCIRG1 SLC34A2 SLC34A3 GRM1 SLC10A7 SLC4A3 SLC1A7 STT3A SLC4A1 SLC13A4 CLCN2 CLCNKA SCN4A ATP2A3 SLC14A2 SLC17A6 | 3.41e-06 | 1029 | 125 | 19 | CID000000312 |
| Drug | Carbodiimide wscd | 3.92e-06 | 20 | 125 | 4 | CID000122346 | |
| Drug | strychnine HCl | 7.28e-06 | 181 | 125 | 8 | CID000005304 | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 6379_UP | |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 3627_UP | |
| Drug | NPS R-568 | 1.38e-05 | 27 | 125 | 4 | CID000158796 | |
| Drug | pseudococaine | IL13RA1 HTR2B HTR2C GRM1 GRM3 SLC1A7 SCN3A SCN4A SCN5A CCR3 MMP15 ATP2A3 SLC17A6 | 1.57e-05 | 570 | 125 | 13 | CID000002826 |
| Drug | SF303 | 1.82e-05 | 59 | 125 | 5 | CID005362436 | |
| Drug | 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | 1.86e-05 | 206 | 125 | 8 | CID000040600 | |
| Drug | malonate | 2.07e-05 | 209 | 125 | 8 | CID000000867 | |
| Drug | AC1L9B0M | 2.43e-05 | 31 | 125 | 4 | CID000003148 | |
| Drug | tetradotoxin | HTR2B HTR2C SPN GRM1 GRM3 ADORA3 SCN3A SCN4A SCN5A SCN8A BAMBI | 2.48e-05 | 428 | 125 | 11 | CID000020382 |
| Drug | quindine | 2.89e-05 | 219 | 125 | 8 | CID000001065 | |
| Drug | flufenamic acid | 2.94e-05 | 108 | 125 | 6 | CID000003371 | |
| Drug | Flecainide | 2.99e-05 | 2 | 125 | 2 | DB01195 | |
| Drug | Ro 60-0175 | 2.99e-05 | 2 | 125 | 2 | ctd:C103848 | |
| Drug | AC1Q1YRG | 2.99e-05 | 2 | 125 | 2 | CID000105432 | |
| Drug | SB 228357 | 2.99e-05 | 2 | 125 | 2 | ctd:C118947 | |
| Drug | SB-228357 | 2.99e-05 | 2 | 125 | 2 | CID000443390 | |
| Drug | AC1LCF1F | 3.08e-05 | 161 | 125 | 7 | CID000627275 | |
| Drug | potassium | HTR2C HCN3 TCIRG1 GRM1 GRM3 SLC1A7 UCN2 SLC4A1 ADORA3 SLC11A1 CLCN2 KCNC1 CLCNKA SCN3A SCN4A SCN5A ATP2A3 | 3.73e-05 | 1008 | 125 | 17 | CID000000813 |
| Drug | gabapentin | 4.19e-05 | 169 | 125 | 7 | CID000003446 | |
| Drug | Sordinol | 4.44e-05 | 13 | 125 | 3 | CID000012453 | |
| Drug | atomoxetine | 4.45e-05 | 36 | 125 | 4 | CID000054840 | |
| Drug | Aloxi | 4.45e-05 | 36 | 125 | 4 | CID000148211 | |
| Drug | flecainide | 4.48e-05 | 71 | 125 | 5 | CID000003355 | |
| Drug | 2-butenedioate | 4.63e-05 | 234 | 125 | 8 | CID000000723 | |
| Drug | almotriptan | 5.53e-05 | 38 | 125 | 4 | CID000123606 | |
| Drug | prilocaine | 5.63e-05 | 14 | 125 | 3 | CID000004906 | |
| Drug | Tetrodotoxin | 6.79e-05 | 40 | 125 | 4 | ctd:D013779 | |
| Drug | desvenlafaxine | 7.49e-05 | 41 | 125 | 4 | CID000125017 | |
| Drug | alunite | 7.49e-05 | 41 | 125 | 4 | CID000062667 | |
| Drug | 1-(3-chlorophenyl)piperazine | 8.59e-05 | 16 | 125 | 3 | ctd:C015068 | |
| Drug | Fenfluramine | 8.94e-05 | 3 | 125 | 2 | DB00574 | |
| Drug | 9-(2-Deoxy-5-O-Phosphono-Beta-D-Erythro-Pentofuranosyl)-6-(Phosphonooxy)-9h-Purine | 8.94e-05 | 3 | 125 | 2 | CID009549204 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 8.94e-05 | 3 | 125 | 2 | ctd:C561228 | |
| Drug | Me-M | 8.94e-05 | 3 | 125 | 2 | CID000077590 | |
| Drug | spiramide | 8.94e-05 | 3 | 125 | 2 | CID000068186 | |
| Drug | WAY-181187 | 8.94e-05 | 3 | 125 | 2 | CID010150497 | |
| Drug | ketanserinol | 8.94e-05 | 3 | 125 | 2 | CID000156394 | |
| Drug | Norfenfluramine | 8.94e-05 | 3 | 125 | 2 | ctd:D009642 | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 195 | 125 | 7 | 2278_DN | |
| Drug | tetrapentylammonium | 1.04e-04 | 17 | 125 | 3 | CID000017248 | |
| Drug | Zonisamide | 1.04e-04 | 17 | 125 | 3 | DB00909 | |
| Drug | AC1L1BXF | 1.06e-04 | 85 | 125 | 5 | CID000001650 | |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; MCF7; HG-U133A | 1.07e-04 | 196 | 125 | 7 | 341_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 2564_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5309_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 6274_UP | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 4116_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 1.10e-04 | 197 | 125 | 7 | 3_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 6043_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 1809_DN | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5773_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 125 | 7 | 5787_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 4703_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 3722_UP | |
| Drug | Metyrapone [54-36-4]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.14e-04 | 198 | 125 | 7 | 6447_UP | |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 3320_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.17e-04 | 199 | 125 | 7 | 61_UP | |
| Drug | Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A | 1.17e-04 | 199 | 125 | 7 | 4354_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | 1.21e-04 | 200 | 125 | 7 | 1574_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 1872_DN | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 125 | 7 | 2814_UP | |
| Drug | alpha-quarterthiophene | 1.24e-04 | 18 | 125 | 3 | CID000395493 | |
| Drug | xenon | 1.25e-04 | 88 | 125 | 5 | CID000023991 | |
| Drug | norfluoxetine | 1.29e-04 | 47 | 125 | 4 | CID000004541 | |
| Drug | NaCN | 1.29e-04 | 47 | 125 | 4 | CID000008929 | |
| Drug | 1-PP | 1.47e-04 | 19 | 125 | 3 | CID000088747 | |
| Drug | duloxetine | 1.52e-04 | 49 | 125 | 4 | CID000060834 | |
| Drug | V ms | 1.52e-04 | 49 | 125 | 4 | CID005289556 | |
| Drug | 2D7 | 1.52e-04 | 49 | 125 | 4 | CID005327103 | |
| Drug | AC1Q5UBL | 1.57e-04 | 146 | 125 | 6 | CID000005466 | |
| Drug | Nicorette | IL13RA1 HTR2B HTR2C GRM1 GRM3 ADORA3 KCNC1 SCN3A SCN4A LYNX1 MMP15 | 1.64e-04 | 529 | 125 | 11 | CID000000942 |
| Drug | methylnaltrexone | 1.72e-04 | 20 | 125 | 3 | CID005361917 | |
| Drug | (ch3)2cnh2 | 1.78e-04 | 4 | 125 | 2 | CID000520257 | |
| Drug | PIM-35 | 1.78e-04 | 4 | 125 | 2 | CID000195658 | |
| Drug | mesulergine | 1.78e-04 | 4 | 125 | 2 | ctd:C031649 | |
| Drug | gamma-valerolactone | 1.78e-04 | 4 | 125 | 2 | CID000007921 | |
| Drug | 2-aminopropane hydrochloride | 1.78e-04 | 4 | 125 | 2 | CID000027399 | |
| Drug | tropanserin | 1.78e-04 | 4 | 125 | 2 | CID000068599 | |
| Drug | trimethoxyamphetamine | 1.78e-04 | 4 | 125 | 2 | CID000031016 | |
| Drug | Tegaserod | 1.78e-04 | 4 | 125 | 2 | DB01079 | |
| Drug | AC1L19UR | 1.78e-04 | 4 | 125 | 2 | CID000025833 | |
| Drug | SB-243213 | 1.78e-04 | 4 | 125 | 2 | CID000443391 | |
| Drug | Pilocarpine | 1.82e-04 | 285 | 125 | 8 | ctd:D010862 | |
| Drug | Methoxychlor | CYP2D6 HTR2C HCN4 GRM3 SLC4A1 IGF1R KCNC1 PELP1 SCN4A ATP2A3 SLC17A6 | 2.26e-04 | 549 | 125 | 11 | ctd:D008731 |
| Drug | N-palmitoyl-l-methionine | 2.31e-04 | 22 | 125 | 3 | CID000486207 | |
| Drug | dapivirine | 2.31e-04 | 22 | 125 | 3 | CID000214347 | |
| Drug | eletriptan | 2.55e-04 | 56 | 125 | 4 | CID000077993 | |
| Drug | glutamate | TAS1R3 ARL6IP5 BCAT2 SLC13A3 GRM1 GRM3 SLC1A7 SLC4A1 ADORA3 CLCN2 CLCNKA SCN4A BAMBI JPH3 SLC17A6 | 2.59e-04 | 962 | 125 | 15 | CID000000611 |
| Drug | darunavir | 2.64e-04 | 23 | 125 | 3 | CID000213039 | |
| Drug | CID5255110 | 2.73e-04 | 57 | 125 | 4 | CID005255110 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.18e-08 | 10 | 119 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.18e-08 | 10 | 119 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.21e-07 | 12 | 119 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.40e-07 | 163 | 119 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | Drug toxicity | 1.19e-06 | 84 | 119 | 6 | C0013221 | |
| Disease | Adverse reaction to drug | 1.19e-06 | 84 | 119 | 6 | C0041755 | |
| Disease | Sick sinus syndrome | 4.83e-05 | 3 | 119 | 2 | cv:C0037052 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 4.83e-05 | 3 | 119 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Familial sick sinus syndrome | 4.83e-05 | 3 | 119 | 2 | cv:C0340491 | |
| Disease | waist-hip ratio | HLA-C HCN4 SLC38A9 SLC13A3 ITGB3 SLC35F5 ADAMTS10 IGF1R ADAMTS6 HSD17B6 DNAH17 SCN4A NMBR SLC14A2 SMIM30 | 1.26e-04 | 1226 | 119 | 15 | EFO_0004343 |
| Disease | Heart valve disease | 1.55e-04 | 26 | 119 | 3 | C0018824 | |
| Disease | Grand Mal Status Epilepticus | 1.58e-04 | 67 | 119 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.58e-04 | 67 | 119 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.58e-04 | 67 | 119 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.58e-04 | 67 | 119 | 4 | C0751523 | |
| Disease | Petit mal status | 1.58e-04 | 67 | 119 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.58e-04 | 67 | 119 | 4 | C0393734 | |
| Disease | sick sinus syndrome (is_implicated_in) | 1.60e-04 | 5 | 119 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 1.60e-04 | 5 | 119 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | Status Epilepticus | 1.68e-04 | 68 | 119 | 4 | C0038220 | |
| Disease | Sick Sinus Syndrome | 2.39e-04 | 6 | 119 | 2 | C0037052 | |
| Disease | osteoporosis (is_implicated_in) | 2.65e-04 | 31 | 119 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 3.34e-04 | 7 | 119 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 3.34e-04 | 7 | 119 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 3.34e-04 | 7 | 119 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | heart function measurement | 3.49e-04 | 34 | 119 | 3 | EFO_0004311 | |
| Disease | Brugada syndrome | 4.44e-04 | 8 | 119 | 2 | cv:C1142166 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 4.44e-04 | 8 | 119 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | Scoliosis, unspecified | 4.44e-04 | 8 | 119 | 2 | C0036439 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 4.44e-04 | 8 | 119 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | asthma (is_implicated_in) | 4.49e-04 | 157 | 119 | 5 | DOID:2841 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 4.50e-04 | 37 | 119 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | factor VIII measurement | 5.67e-04 | 40 | 119 | 3 | EFO_0004630 | |
| Disease | Tremor, Neonatal | 5.70e-04 | 9 | 119 | 2 | C0235843 | |
| Disease | Tremor, Perioral | 5.70e-04 | 9 | 119 | 2 | C0235078 | |
| Disease | Nerve Tremors | 5.70e-04 | 9 | 119 | 2 | C0235083 | |
| Disease | Tremor, Limb | 5.70e-04 | 9 | 119 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 5.70e-04 | 9 | 119 | 2 | C0235082 | |
| Disease | Senile Tremor | 5.70e-04 | 9 | 119 | 2 | C0149840 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 5.70e-04 | 9 | 119 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Pill Rolling Tremor | 5.70e-04 | 9 | 119 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 5.70e-04 | 9 | 119 | 2 | C0751565 | |
| Disease | Action Tremor | 5.70e-04 | 9 | 119 | 2 | C0234376 | |
| Disease | Passive Tremor | 5.70e-04 | 9 | 119 | 2 | C0234377 | |
| Disease | Static Tremor | 5.70e-04 | 9 | 119 | 2 | C0234378 | |
| Disease | Resting Tremor | 5.70e-04 | 9 | 119 | 2 | C0234379 | |
| Disease | Intermittent Tremor | 5.70e-04 | 9 | 119 | 2 | C0234372 | |
| Disease | Fine Tremor | 5.70e-04 | 9 | 119 | 2 | C0234373 | |
| Disease | Coarse Tremor | 5.70e-04 | 9 | 119 | 2 | C0234374 | |
| Disease | Massive Tremor | 5.70e-04 | 9 | 119 | 2 | C0234375 | |
| Disease | Persistent Tremor | 5.70e-04 | 9 | 119 | 2 | C0234370 | |
| Disease | Continuous Tremor | 5.70e-04 | 9 | 119 | 2 | C0234371 | |
| Disease | Darkness Tremor | 5.70e-04 | 9 | 119 | 2 | C0234381 | |
| Disease | Involuntary Quiver | 5.70e-04 | 9 | 119 | 2 | C1527384 | |
| Disease | Saturnine Tremor | 5.70e-04 | 9 | 119 | 2 | C0040827 | |
| Disease | Shortened QT interval | 8.66e-04 | 11 | 119 | 2 | C0151879 | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 8.66e-04 | 11 | 119 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | Tremor | 8.66e-04 | 11 | 119 | 2 | C0040822 | |
| Disease | eosinophil percentage of leukocytes | HLA-C HLA-G SLAMF1 ITGB3 PELP1 HSD17B6 CCR3 TNFRSF1B SMIM30 NOTCH2 | 9.00e-04 | 746 | 119 | 10 | EFO_0007991 |
| Disease | ximenoylcarnitine (C26:1) measurement | 1.22e-03 | 13 | 119 | 2 | EFO_0800543 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 1.22e-03 | 13 | 119 | 2 | DOID:676 (is_implicated_in) | |
| Disease | Brugada Syndrome 1 | 1.22e-03 | 13 | 119 | 2 | C4551804 | |
| Disease | nervous system disorder | 1.29e-03 | 53 | 119 | 3 | C0027765 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.29e-03 | 53 | 119 | 3 | C4707243 | |
| Disease | lymphocyte measurement | 1.31e-03 | 117 | 119 | 4 | EFO_0803546 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 1.42e-03 | 14 | 119 | 2 | DOID:841 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.64e-03 | 15 | 119 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.64e-03 | 15 | 119 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.64e-03 | 15 | 119 | 2 | C0154091 | |
| Disease | Graves' disease (is_marker_for) | 1.64e-03 | 15 | 119 | 2 | DOID:12361 (is_marker_for) | |
| Disease | anemia (implicated_via_orthology) | 1.64e-03 | 15 | 119 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 1.76e-03 | 59 | 119 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.76e-03 | 59 | 119 | 3 | C0037286 | |
| Disease | lymphocyte count | HLA-C PCDHGB5 RNF19A SLC38A9 HLA-G TUNAR PLXNB2 SLC4A1 TMEM171 CD82 DNAH17 CPNE1 TM2D1 NOTCH2 | 2.34e-03 | 1464 | 119 | 14 | EFO_0004587 |
| Disease | Carcinoma of bladder | 2.37e-03 | 18 | 119 | 2 | C0699885 | |
| Disease | left ventricular mass | 2.37e-03 | 18 | 119 | 2 | EFO_0009289 | |
| Disease | glomerulonephritis (is_marker_for) | 2.64e-03 | 19 | 119 | 2 | DOID:2921 (is_marker_for) | |
| Disease | factor VIII measurement, Ischemic stroke | 2.64e-03 | 19 | 119 | 2 | EFO_0004630, HP_0002140 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.89e-03 | 239 | 119 | 5 | EFO_0010934 | |
| Disease | lung cancer | 3.22e-03 | 21 | 119 | 2 | MONDO_0008903 | |
| Disease | Nephritis, Tubulointerstitial | 3.22e-03 | 21 | 119 | 2 | C0041349 | |
| Disease | disease | 3.22e-03 | 21 | 119 | 2 | EFO_0000408 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 3.53e-03 | 22 | 119 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.53e-03 | 22 | 119 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.86e-03 | 23 | 119 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.86e-03 | 23 | 119 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.86e-03 | 23 | 119 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.86e-03 | 23 | 119 | 2 | C0014556 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVAAAVPALLVLILI | 986 | P48751 | |
| ILMVIIPTIGGNTLV | 61 | P41595 | |
| VAVLVGLSILMEPIL | 766 | P02730 | |
| VSGLVGQLLMQPVLV | 541 | P46379 | |
| LADIAVGVLVMPLAI | 56 | P0DMS8 | |
| VGVLVMPLAIVVSLG | 61 | P0DMS8 | |
| ICLGLILVQIVMVSV | 691 | Q14832 | |
| PALSIVIIIIMTIGG | 56 | P28335 | |
| VIIIIMTIGGNILVI | 61 | P28335 | |
| IVNASRLPMSIIIVG | 441 | O75131 | |
| LLRLPQVAMATGQVL | 96 | Q9UK58 | |
| PLVIMLILVANAIVG | 91 | Q93084 | |
| LGPINASLIVMVLAR | 791 | Q9H324 | |
| ALGPTSENLIVMVLL | 801 | Q9UKP5 | |
| VGVAIIELLGMVLSI | 236 | P27701 | |
| MAVVIRLQGLPIVAG | 1 | Q9NTZ6 | |
| PLIVIPVVLTVAMAG | 121 | O60896 | |
| LTVRVSVPIIMGVNV | 151 | Q8N130 | |
| VVTVVGNLGMILLIA | 36 | Q8WZ84 | |
| IPIMGIVAGLVVLAA | 306 | P17693 | |
| TVMVVVGRNIPVTLI | 351 | Q9NXN4 | |
| SQLFMTVVVPLIIGQ | 171 | Q0GE19 | |
| TLVIVVLMPPEQLLQ | 1546 | Q04721 | |
| TPLILAARLAVEGMV | 1946 | Q04721 | |
| LLIITVGLLGNIMLV | 51 | P28336 | |
| NIVVILLLVALLGSM | 201 | Q6P499 | |
| PERLAAGTLVVVVLM | 1566 | P46531 | |
| NSRGMLPVAVLVALL | 251 | P16150 | |
| LTVALMPVLNQVAGL | 211 | Q5RKV6 | |
| MRPGTALQAVLLAVL | 1 | Q6UX15 | |
| ARTVNVVMVLVPLLL | 621 | P51511 | |
| AIGPVIGIILSLFVM | 1386 | O75197 | |
| PVAVLLIVGGLVIML | 941 | P08069 | |
| IPIMGIVAGLAVLVV | 306 | P10321 | |
| ILPLVIVPMVVVIAV | 1201 | O15031 | |
| IMLGVSLAILLIGVV | 711 | P18564 | |
| IGTMVVLRAAILVAP | 146 | Q9UKL2 | |
| VAIMLGNLLILVTVI | 36 | Q8NGD5 | |
| VIGVVAGIMTVILII | 881 | O60245 | |
| NPAALVVVLMAVLLL | 1411 | Q9UBG0 | |
| LLQAVGIVGAIIMPH | 241 | P49279 | |
| QTGMVPLLEVALQTI | 911 | Q96RT7 | |
| GVGVMVLVIPINAIL | 466 | Q92887 | |
| MILENAVPGTLIALI | 351 | Q9Y5G0 | |
| IVVGINIMVPSCTIL | 201 | Q8NGG8 | |
| LLLMVGNLIVLPVGI | 101 | Q9P1Z3 | |
| LVLPLVMGVQQGEVL | 551 | Q8IZL8 | |
| LAVAGEAPVLIMILL | 196 | Q9UGQ3 | |
| LLMVGNLIIIPVGIT | 271 | Q9Y3Q4 | |
| ITMLLIVPVIVAGAI | 346 | P78552 | |
| AVAVTVLGIMILGLI | 201 | Q9UKJ1 | |
| IIGLGVALLLVLVIM | 1156 | Q9BYE9 | |
| ALAGVLTIAMPVPVI | 421 | P48547 | |
| VNLIGVIQVTLSMLP | 136 | O14756 | |
| ILVLIPGNPMLNIIV | 726 | Q96PB1 | |
| GIPQAGLVTMVIVLT | 421 | O00341 | |
| AVPIAGGLILVLLIM | 156 | Q13145 | |
| TVGLLGNVVVVMILI | 46 | P51677 | |
| IIGLIPTVGIFITMN | 1936 | Q9UFH2 | |
| LLRLPQVAMATGQVL | 91 | Q96S94 | |
| MGLEALVPLAVIVAI | 1 | P10635 | |
| CIVMTLAVLQPLLAV | 451 | Q6ZNA5 | |
| MAAGPIRVVLVLLGV | 1 | Q495W5 | |
| PCAVALPIIVVILMI | 246 | Q7KYR7 | |
| TLILVVLMGLPLAQA | 6 | P0DP58 | |
| APLLTVILALVGMEA | 351 | Q4ZIN3 | |
| GPDILVVLLSVMGAI | 716 | P05106 | |
| IPLVLLVVLVFAGMG | 461 | Q8N8Z6 | |
| VQLTLVVTLIIMEPP | 716 | Q13255 | |
| VILPGVVRQSLLDMA | 291 | O15382 | |
| RLMVPAGQGLIVVIS | 136 | Q96LJ7 | |
| ILMLVGVQPARLILG | 116 | Q8WWT9 | |
| LGVNVIGLVIVMVAI | 586 | Q9UKG4 | |
| PQLAAMIITLSLQGV | 206 | Q504Y0 | |
| VLILNLIIVGAGVIM | 481 | Q8NBW4 | |
| MEVLVLGVAQRSLPL | 266 | P11474 | |
| LGQIVSSQVLTLPLM | 101 | Q99829 | |
| IISVLVLVVPMGLVF | 211 | P30954 | |
| LVMVVGNLLIILAIS | 36 | Q8NGA1 | |
| LMILLGNGVLISVII | 36 | Q8NGS7 | |
| QVLVGISMCIVIRPV | 141 | Q8NH60 | |
| ISGLNALQLRLMVPV | 51 | Q96S52 | |
| ISLIAGIAIPAMVIG | 361 | Q6ZMZ0 | |
| TITELGAPVEMIQLL | 231 | Q504Y2 | |
| VLMCIIINGLIGTVL | 396 | Q8WV83 | |
| MRVVVNALLGAIPSI | 1146 | P35499 | |
| VLELRVQPVMGISLT | 636 | Q24JP5 | |
| ILGVLISIIGIAMAV | 66 | Q86VY9 | |
| VVLQLLVGVPLEMVH | 231 | P58872 | |
| LSPFNMILGGIVVVL | 61 | O75915 | |
| MQQVTLVLLGHILPG | 776 | O75448 | |
| ALVGAIPSIMNVLLV | 1326 | Q14524 | |
| GGVIMILIMVVILQL | 246 | Q13291 | |
| INLIPLHVLVLMLTG | 216 | P46977 | |
| VLMSLLLVLPVVEAV | 11 | A4D0T7 | |
| TVPLNLIRVHLMVAV | 1091 | Q9NT68 | |
| NALVGAIPSIMNVLL | 1326 | Q9NY46 | |
| LVNVVGNIGMIILIT | 36 | Q8NGP9 | |
| IGMIILISISPQLQS | 41 | Q8NGP3 | |
| VPLIVGILLVLMAVV | 596 | P40967 | |
| MAAIGPVILIHQILQ | 136 | Q96J65 | |
| MSLGIVLSIPVNAVI | 331 | Q8IY50 | |
| LSNPGLVIAVILVMV | 696 | Q8TDI8 | |
| LTGQIVHALPVLMAV | 491 | P51800 | |
| GQIAHILPVMIAVIL | 526 | P51788 | |
| ILPVMIAVILANAVA | 531 | P51788 | |
| LTVRAAIPIIMGANI | 176 | O95436 | |
| HLVMTIIVPIGGQIA | 356 | Q9P2U8 | |
| AVDPAILLIVVGVLM | 61 | Q86UF1 | |
| MLGIIGTILNLIVII | 26 | A0A1B0GTB2 | |
| QVVLRPAVQMGALLL | 786 | Q7RTX0 | |
| TAQQPRLFVGMILIL | 121 | P27449 | |
| ALIAGIAIPAMIIGI | 376 | Q9NV58 | |
| DVMSGLIVGILLVPQ | 111 | P50443 | |
| SLIDFILISMQIVGP | 161 | Q9BX74 | |
| VGAIPSIMNVLLVCL | 1321 | Q9UQD0 | |
| IFSPLGITLVLEMVQ | 46 | O75830 | |
| LSLQIMGPLIVLVGL | 161 | Q8WVE6 | |
| LQSLMGVLPDLVVEI | 911 | Q92543 | |
| SVIPLLRESVGILMQ | 281 | Q8NEW0 | |
| VQVQTLIVVIIGMLV | 226 | Q9H8X9 | |
| ELTPIAIMAGRLLVQ | 366 | Q9NNW7 | |
| MLTPVSVGGLIVNLI | 521 | Q8TAD4 | |
| VLMLGRVLVVPVTPI | 11 | Q96RP3 | |
| LGLLIIGVVNCVIMT | 271 | P20333 | |
| RVLTILEQIPGMVVV | 396 | Q8NHP8 | |
| VMFVNNPLSGILIIL | 591 | Q15849 | |
| VVQATLVVLALAMVP | 631 | Q13488 | |
| PILVVMVILLNIGVA | 726 | Q8WXH2 |